Cresset Asset Management, LLC Novo Nordisk A S Transaction History

Cresset Asset Management, LLC

$25.6 Billion
Q3 2024

A detailed history of Cresset Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cresset Asset Management, LLC holds 142,610 shares of NVO stock, worth $15.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

142,610

Previous 142,778 0.12%

Holding current value

$15.1 Million

Previous $20.4 Million 16.68%

% of portfolio

0.07%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $20,003 - $24,430	-168 Reduced 0.12%	142,610 $17 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $2.27 Million - $2.71 Million	18,466 Added 14.85%	142,778 $20.4 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $1.68 Million - $2.23 Million	16,420 Added 15.22%	124,312 $16 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $383,247 - $460,394	-4,366 Reduced 3.89%	107,892 $11.2 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $5.35 Million - $11.7 Million	58,792 Added 109.96%	112,258 $10.2 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $6.32 Million - $6.99 Million	40,500 Added 312.36%	53,466 $8.65 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $84,168 - $101,213	-636 Reduced 4.68%	12,966 $2.06 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $207,663 - $274,043	-2,025 Reduced 12.96%	13,602 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $188,559 - $231,404	1,979 Added 14.5%	15,627 $1.56 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $227,540 - $268,469	2,204 Added 19.26%	13,648 $1.49 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $161,900 - $195,707	-1,739 Reduced 13.19%	11,444 $1.28 Million
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $825,622 - $1.01 Million	-8,611 Reduced 39.51%	13,183 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $248,532 - $313,889	2,944 Added 15.62%	21,794 $2.09 Million
Q2 2021 Aug 10, 2021	SELL	$67.66 - $84.76 $191,883 - $240,379	-2,836 Reduced 13.08%	18,850 $1.58 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $206,142 - $233,070	3,074 Added 16.52%	21,686 $1.48 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $3,513 - $4,059	55 Added 0.3%	18,612 $1.3 Million
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $1,910 - $2,106	-30 Reduced 0.16%	18,557 $1.29 Million
Q2 2020 Aug 04, 2020	BUY	$58.54 - $67.94 $564,793 - $655,485	9,648 Added 107.93%	18,587 $1.22 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $46,789 - $61,281	-946 Reduced 9.57%	8,939 $545,000
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $42,331 - $49,462	849 Added 9.4%	9,885 $572,000
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $33,468 - $37,614	704 Added 8.45%	9,036 $467,000
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $118,940 - $133,378	-2,542 Reduced 23.38%	8,332 $425,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $380,476 - $431,934	8,207 Added 307.72%	10,874 $577,000
Q4 2018 May 21, 2019	BUY	$41.54 - $47.25 $110,787 - $126,015	2,667 New	2,667 $123,000

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $239B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Novo Nordisk A S Transaction History